| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.7B | $14.4B | $13.9B | $12.8B | $13.1B | $11.6B | $12.5B | $11.9B |
| Cost of Revenue | $8.4B | $8.7B | $8.3B | $7.6B | $7.8B | $7.0B | $7.7B | $7.3B |
| Gross Profit | $5.3B | $5.6B | $5.6B | $5.2B | $5.3B | $4.6B | $4.9B | $4.6B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.8B | $3.9B | $3.9B | $3.5B | $3.6B | $3.3B | $3.6B | $3.4B |
| Operating Income | $1.0B | $1.2B | $1.4B | $1.6B | $1.5B | $1.0B | $0.9B | $0.9B |
| Net Income | $0.6B | $0.7B | $0.9B | $1.1B | $1.1B | $0.6B | $0.5B | $0.5B |
| EPS (Basic) | $2.36 | $2.62 | $3.50 | $4.15 | $3.68 | $2.10 | $1.75 | $1.53 |
| EPS (Diluted) | $2.35 | $2.62 | $3.49 | $4.13 | $3.66 | $2.09 | $1.74 | $1.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.1B | $15.0B | $15.1B | $12.0B | $12.6B | $12.4B | $12.8B | $11.4B |
| Current Assets | $5.2B | $4.9B | $4.9B | $4.3B | $4.3B | $4.0B | $4.7B | $4.5B |
| Cash & Equivalents | $0.3B | $0.2B | $0.3B | $0.3B | — | — | — | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.1B | $2.9B | $3.3B | $2.3B | $2.2B | $2.0B | $2.2B | $1.7B |
| Stockholders' Equity | $6.5B | $6.0B | $6.2B | $5.5B | $5.8B | $5.7B | $5.0B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $1.4B | $1.3B | $1.4B | $1.4B | $1.1B | $0.7B |
| Investing Cash Flow | $0.2B | $-0.4B | $-2.4B | $0.2B | $-0.4B | $-0.2B | $-0.3B | $-1.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.2B | $-0.7B | $1.1B | $-1.4B | $-1.0B | $-1.5B | $-0.6B | $0.9B |